EGFR and neoplasm: In contrast, we show that EGFR amplification present in the primary tumour was retained in the recurrent tumour after treatment with radiotherapy and temozolomide, in line with a recent report showing relative stability of EGFR amplification and EGFRvIII mutation within paired primary and recurrent glioblastomas25,26.